Kurzfassung

PANDA-1 A Multicenter, Double-Masked, Randomized,
Dose-Ranging Trial to Evaluate the Efficacy and
Safety of Conbercept Intravitreal Injection in
Subjects with Neovascular Age-related Macular
Degeneration